The interplay of adverse environmental factors and predisposing genetic alterations can lead to the development of inflammatory bowel disease such as ulcerative colitis. Gut bacteria play an important role in this context and endogenous anti-microbial peptides contribute to regulating their diversity. In this project, we will produce a modified anti-microbial peptide for subsequent clinical testing.

Further information here.